LABT US EQUITY Health Care Health Care CIK: 2079272

Lakewood-Amedex Biotherapeutics Inc. (LABT) Quant Factor Diagnostic & Fair Value Model

Lakewood-Amedex Biotherapeutics Inc. (Ticker: LABT) is listed in the Health Care sector (Health Care). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.

0.00% Latest Close (Latest)

Market Cap: -

P/E Ratio: -

Momentum Strength 3M / 12M

1M: - 12M: -

Quality (ROE) Point-in-Time

Trailing Return on Equity

Technical Trend RSI 14

SMA50: - SMA200: -

Valuation Multiplier Trailing

Pre-Profit / Negative TTM

📊 Valuation & Multi-Factor Diagnostic

Pre-Profit / Negative TTM

LABT has negative or near-zero trailing GAAP earnings over the trailing twelve months.

Compare in Screener

⚡ Benchmark Factor Strategy

S&P 500 Momentum Alpha Strategy

This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.

Strategy Marketplace Open Strategy →

📈 Daily Candlestick & Volume Quant Chart

Interactive lightweight price action & volume breakdown over recent 90 trading days.

均线多头 (MA20/50) Piotroski F-Score: 0/9 (Under Pressure or Early Stage Growth)

Official Point-in-Time Financial Filing History

Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.

备案 CIK: 2079272 · 10-K 年报 / 10-Q 季报

Form	Period End	Filing Timestamp (Point-in-Time)	Revenue	Net Income	Operating CF	EPS (Diluted)
No point-in-time filings synced yet. Automated batch scheduler will align CIK: 2079272

💡 Methodology & Frequently Asked Questions

Key reference details regarding Lakewood-Amedex Biotherapeutics Inc. (LABT) valuation multiples, momentum factors, and point-in-time filing conventions.

How should LABT's current valuation multiple be interpreted? ↓

LABT trades at a trailing P/E of -x within the Health Care sector (pre-profit / negative ttm). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.

What are LABT's key momentum and technical factor indicators? ↓

As of the latest close, LABT shows a 1-month return of -, 3-month return of -, and 12-month return of -, with a 14-day RSI of -. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.

What is Point-in-Time (PIT) financial data and why does it matter for LABT? ↓

Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.

How can LABT be incorporated into systematic factor models? ↓

LABT can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.